|
In Remembrance
|
|
Join Date: Aug 2006
Location: Florida
Posts: 3,904
|
|
|
In Remembrance
Join Date: Aug 2006
Location: Florida
Posts: 3,904
|
wonder how much money was wasted here
....since that's all that counts.....paula
Reuters
Tue Sep 1, 2009 11:34am EDT
* Drug misses antipsychotic efficacy goal
* Acadia co-developing the drug with Biovail
* Acadia shares sink 68 pct; Biovail down 2 pct (Adds analyst comment, bylines; updates shares)
By Lewis Krauskopf and Ransdell Pierson
NEW YORK, Sept 1 (Reuters) - Acadia Pharmaceuticals Inc (ACAD.O: Quote, Profile, Research, Stock Buzz) said on Tuesday its experimental drug for psychosis related to Parkinson's disease failed to meet its primary goal in a late-stage trial, sending its shares down 68 percent.
From article:
Patients in the 298-patient trial who were taking pimavanserin showed improvement in psychosis measures, but the difference was not statistically significant. Acadia said the lack of a significant difference was primarily due to the larger-than-expected improvement in patients taking the placebo.
http://www.reuters.com/article/rbssPharmaceuticals%20-%20Diversified/idUSBNG48310420090901?sp=true
__________________
paula
"Time is not neutral for those who have pd or for those who will get it."
Last edited by paula_w; 09-01-2009 at 02:12 PM.
|